S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead

Intellipharmaceutics International (IPCIF) Earnings Date, Estimates & Call Transcripts

$0.06
0.00 (0.00%)
(As of 04/15/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

IPCIF Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

IPCIF Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

IPCIF Earnings Date and Information

Intellipharmaceutics International has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, June 3rd, 2024 based off prior year's report dates.

Intellipharmaceutics International Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
6/3/2024
Estimated)
------- 
10/16/2023Q3 2023-($0.06)($0.06)($0.06)-$0.07 million
6/6/2023Q1 2023-($0.01)($0.01)($0.01)-$0.33 million
10/14/2022Q3 2022-($0.01)($0.01)($0.01)-$0.02 million
7/21/2022Q2 2022-($0.05)($0.05)($0.07)--
4/14/2022Q1 2022-($0.03)($0.03)($0.03)-$0.08 million
2/28/2022Q4 2021-($0.17)($0.17)($0.17)--
10/15/2021Q3 2021-($0.04)($0.04)($0.04)--
7/15/2021Q2 2021-($0.04)($0.04)($0.04)-$0.09 million

Intellipharmaceutics International Earnings - Frequently Asked Questions

When is Intellipharmaceutics International's earnings date?

Intellipharmaceutics International has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, June 3rd, 2024 based off last year's report dates. Learn more on IPCIF's earnings history.

How much revenue does Intellipharmaceutics International generate each year?

Intellipharmaceutics International (OTCMKTS:IPCIF) has a recorded annual revenue of $660,000.00.

How much profit does Intellipharmaceutics International generate each year?

Intellipharmaceutics International (OTCMKTS:IPCIF) has a recorded net income of -$2.89 million. IPCIF has generated -$0.16 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

This page (OTCMKTS:IPCIF) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners